Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma

Yibin Yang(National Institutes of Health), Arthur L. Shaffer(National Institutes of Health), N. C. Tolga Emre(National Institutes of Health), Michele Ceribelli(National Institutes of Health), Meili Zhang(National Institutes of Health), George W. Wright(National Institutes of Health), Wenming Xiao(National Institutes of Health), John Powell(National Institutes of Health), John Platig(National Institutes of Health), Holger Kohlhammer(National Institutes of Health), Ryan M. Young(National Institutes of Health), Hong Zhao(National Institutes of Health), Yandan Yang(National Institutes of Health), Weihong Xu(National Institutes of Health), Joseph J. Buggy(Pharmacyclics (United States)), Sriram Balasubramanian(Pharmacyclics (United States)), Lesley Mathews(National Center for Advancing Translational Sciences), Paul Shinn(National Center for Advancing Translational Sciences), Rajarshi Guha(National Center for Advancing Translational Sciences), Marc Ferrer(National Center for Advancing Translational Sciences), Craig J. Thomas(National Center for Advancing Translational Sciences), Thomas A. Waldmann(National Institutes of Health), Louis M. Staudt(National Institutes of Health)
Cancer Cell
June 1, 2012
10.1016/j.ccr.2012.05.024
Cited by 513Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis